Find uplifting stories about heroes, innovations, and solutions
15 results for "moderna"
A new flu vaccine using the same technology that powered COVID shots just proved more effective than traditional options in a 40,000-person study. The breakthrough could reshape how we protect ourselves from seasonal flu.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
A potentially life-saving bird flu vaccine is moving forward in clinical trials, even after the US government canceled hundreds of millions in funding. International partnership keeps pandemic preparedness effort alive with 4,000 volunteers.
OpenAI just launched GPT-Rosalind, an AI model designed to speed up the painfully slow process of bringing new medicines to patients. Major pharma companies like Moderna and Amgen are already putting it to work.
A new AI tool named after DNA pioneer Rosalind Franklin is helping scientists discover life-saving drugs faster than ever before. Major pharmaceutical companies including Moderna and Amgen are already seeing results.
OpenAI just launched GPT-Rosalind, an AI model designed to speed up the journey from scientific research to life-saving treatments. Major pharmaceutical companies like Amgen and Moderna are already testing it.
Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.
The FDA suddenly agreed to review Moderna's revolutionary mRNA flu vaccine after initially rejecting it just a week earlier. Meanwhile, scientists developed an inhaled vaccine that could protect against multiple respiratory illnesses at once.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
After an unexpected rejection last week, the FDA has reversed course and agreed to review Moderna's new mRNA flu vaccine. Seniors could have a new option to protect against the flu by late 2026.
After rejecting Moderna's flu vaccine application just a week ago, the FDA reversed course and will now review the promising mRNA shot. The new technology could revolutionize how we protect ourselves from seasonal flu.
Britain just approved its first domestically manufactured mRNA vaccine, marking a major milestone in pandemic preparedness. The new Moderna facility in Oxfordshire can produce up to 250 million doses per year during health emergencies.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.
A Moderna immunotherapy for melanoma continues to protect patients years after treatment, new data shows. The results bring hope for a cancer vaccine that could change how we fight one of the deadliest skin cancers.